NO20006545L - Fremgangsmåte for in vitro modning av humane kjönnsceller - Google Patents

Fremgangsmåte for in vitro modning av humane kjönnsceller

Info

Publication number
NO20006545L
NO20006545L NO20006545A NO20006545A NO20006545L NO 20006545 L NO20006545 L NO 20006545L NO 20006545 A NO20006545 A NO 20006545A NO 20006545 A NO20006545 A NO 20006545A NO 20006545 L NO20006545 L NO 20006545L
Authority
NO
Norway
Prior art keywords
medium
maturation
heading
vitro maturation
human gamete
Prior art date
Application number
NO20006545A
Other languages
English (en)
Other versions
NO20006545D0 (no
Inventor
Svend Lindenberg
Anne Lis Mikkelsen
Steven Dale Smith
Kjell Bertheussen
Original Assignee
Medi Cult As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK199900885A external-priority patent/DK199900885A/da
Application filed by Medi Cult As filed Critical Medi Cult As
Publication of NO20006545D0 publication Critical patent/NO20006545D0/no
Publication of NO20006545L publication Critical patent/NO20006545L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/48Regulators of apoptosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00Cells related to new breeds of animals
    • C12N2517/10Conditioning of cells for in vitro fecondation or nuclear transfer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Stringed Musical Instruments (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
NO20006545A 1998-06-22 2000-12-21 Fremgangsmåte for in vitro modning av humane kjönnsceller NO20006545L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9011598P 1998-06-22 1998-06-22
DK199900885A DK199900885A (da) 1998-06-22 Fremgangsmåde for tildeling af et vilkårligt beløb på en given taletidskortkonto
PCT/DK1999/000345 WO1999067365A1 (en) 1998-06-22 1999-06-22 A method for in vitro maturation of human gametes

Publications (2)

Publication Number Publication Date
NO20006545D0 NO20006545D0 (no) 2000-12-21
NO20006545L true NO20006545L (no) 2001-02-21

Family

ID=26064838

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20006519A NO20006519L (no) 1998-06-22 2000-12-20 Analyse for å indikere tilstedeværelse av ikke-fertiliserbare egg
NO20006545A NO20006545L (no) 1998-06-22 2000-12-21 Fremgangsmåte for in vitro modning av humane kjönnsceller

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20006519A NO20006519L (no) 1998-06-22 2000-12-20 Analyse for å indikere tilstedeværelse av ikke-fertiliserbare egg

Country Status (23)

Country Link
US (2) US20020115211A1 (no)
EP (2) EP1088056A1 (no)
JP (1) JP2002519640A (no)
CN (2) CN1161615C (no)
AT (1) ATE407363T1 (no)
AU (2) AU760165B2 (no)
BR (1) BR9911470A (no)
CA (2) CA2335632A1 (no)
DE (1) DE69939468D1 (no)
EE (1) EE200000763A (no)
ES (1) ES2313785T3 (no)
HR (1) HRP20000888A2 (no)
HU (1) HUP0103392A2 (no)
ID (1) ID27197A (no)
IL (2) IL140283A0 (no)
IS (1) IS5768A (no)
NO (2) NO20006519L (no)
NZ (1) NZ509451A (no)
PL (1) PL345318A1 (no)
RU (1) RU2227916C2 (no)
SK (1) SK19152000A3 (no)
TR (1) TR200003830T2 (no)
WO (2) WO1999067365A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050208651A1 (en) * 2002-03-08 2005-09-22 Ri-Cheng Chian Vitro maturation of immature human oocytes
AU2003232183B2 (en) 2002-06-17 2008-08-14 Region Hovedstaden V/Herlev Hospital In vitro fertilisation
ES2368846T3 (es) * 2003-11-26 2011-11-22 Merck Serono Sa Uso de citocinas de tipo il-6 para la maduración de ovocitos.
US20070020755A1 (en) * 2005-07-07 2007-01-25 Teresa Woodruff Stage specific follicle maturation systems
CN103275930B (zh) * 2013-06-20 2014-07-09 江苏皓康生物医药科技有限公司 一种卵母细胞体外成熟培养液及其制备方法
JP6806970B2 (ja) 2014-06-10 2021-01-06 ポリバイオセプト ゲーエムベーハー 細胞免疫療法用培養培地
BR112018068474B1 (pt) * 2016-02-24 2024-01-30 Universitá Degli Studi Di Milano, Unimi Sistema folicular para maturação de oócitos in vitro e kit
CN110628705A (zh) * 2019-10-22 2019-12-31 山东畜牧兽医职业学院 一种驴胚胎冲洗液及其应用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614715A (en) * 1982-05-14 1986-09-30 The Board Of Trustees Of The University Of Illinois Predictive test for impending ovulation in mammals
RU2013989C1 (ru) * 1991-08-13 1994-06-15 Борис Васильевич Леонов Способ определения овуляции
GB9217866D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
EP0734531A1 (en) * 1993-12-16 1996-10-02 Abbott Laboratories Methods and means for determining the female fertile period
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9603326D0 (en) * 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
DE69619236D1 (de) * 1996-09-27 2002-03-21 Unilever Plc Überwachungsverfahren
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media

Also Published As

Publication number Publication date
EP1088056A1 (en) 2001-04-04
CN1313951A (zh) 2001-09-19
AU760165B2 (en) 2003-05-08
EE200000763A (et) 2002-06-17
DE69939468D1 (de) 2008-10-16
ID27197A (id) 2001-03-08
CN1607391A (zh) 2005-04-20
NO20006519D0 (no) 2000-12-20
RU2227916C2 (ru) 2004-04-27
AU4360599A (en) 2000-01-10
IS5768A (is) 2000-12-12
JP2002519640A (ja) 2002-07-02
CA2335793A1 (en) 1999-12-29
AU4360499A (en) 2000-01-10
ATE407363T1 (de) 2008-09-15
US20010028878A1 (en) 2001-10-11
NO20006519L (no) 2001-02-21
WO1999067644A1 (en) 1999-12-29
TR200003830T2 (tr) 2002-01-21
EP1090300B1 (en) 2008-09-03
NZ509451A (en) 2003-03-28
IL140283A0 (en) 2002-02-10
HRP20000888A2 (en) 2001-12-31
EP1090300A1 (en) 2001-04-11
CA2335632A1 (en) 1999-12-29
NO20006545D0 (no) 2000-12-21
WO1999067365A1 (en) 1999-12-29
IL140394A0 (en) 2002-02-10
HUP0103392A2 (hu) 2002-01-28
SK19152000A3 (sk) 2001-12-03
BR9911470A (pt) 2001-03-20
CN1161615C (zh) 2004-08-11
PL345318A1 (en) 2001-12-03
US20020115211A1 (en) 2002-08-22
ES2313785T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
GB2350619A (en) Sex-specific insemination of mammals with low number of sperm cells
WO1999005266A3 (en) Trans-species nuclear transfer
ATE331025T2 (de) Medium für die protein- und serumfreie zellkultur
ATE250664T1 (de) In vitro reifen von oozyten mit inhibitin/activin kombinationen
DK0799058T3 (da) Forbedringer af eller med hensyn til endometriefunktion
ATE67787T1 (de) Verfahren zur herstellung von proteinen mittels induzierbarer expressionssysteme in in-vivovermehrten, genetisch modifizierten eukaryotischen wirtszellen.
NO20006545L (no) Fremgangsmåte for in vitro modning av humane kjönnsceller
AUPP421298A0 (en) Method and medium for in vitro culture of human embryos
HUP0302600A2 (hu) Eljárás petefészektüszők in vitro tenyésztésére
IE890289L (en) Bovine embryo in vitro culture
DE602004028233D1 (de) Klonierverfahren bei der ratte mittels zellkerntransfer
AU2182801A (en) Method for producing adherent animal cells
AU3927599A (en) Source of nuclei for nuclear transfer
EP1356063B8 (en) Expression of multiple proteins in transgenic plants
CA2329283A1 (en) Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
TNSN01128A1 (en) Process for the preparation of a neutrophil inhibitory factor
DE69923595D1 (de) Herstellung von proteinen
UY26907A1 (es) Proceso para preparar un factor inhibidor de neutrófilos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application